FindTrial
Sign In

Homoeopathic treatment of cough and cold in children

Effectiveness of individualized homoeopathic medicines vs. Sabadilla in the treatment of upper respiratory tract infections in children: An open-label randomized pragmatic clinical trial

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012613
Enrollment
100
Registered
2018-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Children with upper respiratory tract infection

Interventions

Intervention1: Sabadilla in centesimal or 50 millesimal potencies: In centesimal scale, each dose consist of a single drop of Sabadilla (preserved in 90% v/v ethanol) in 5 ml of distilled water, to be
dosage and repetition depending upon the individual requirement of the cases. In 50 millesimal scale, a single medicated cane sugar globule of poppy seed size (no. 10) will be dissolved in 90 ml disti
16 doses to be marked on the vial
each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th
dosage and repetition depending upon the individual requirement of the cases. In 50 millesimal scale, a single medicated cane sugar globule of poppy seed size (no. 10) will be dissolved in 90 ml disti
each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th

Sponsors

National Institute of Homoeopathy Ministry of AYUSH Govt of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Preadolescent children (1-11 years of age) 2. Clinical signs and symptoms of an URTI with a duration of up to 24 hours accompanied with or without fever 37.5áµ?C (axillary body temperature) or higher 3. At least 1 of 3 types of URTI symptoms â?? Nasal (plugged nose, runny nose, sneezing), Pharyngeal (scratchy throat, sore throat, pharyngeal hyperaemia), Cough (ordinary cough without suspicion of acute lower respiratory tract disease). 4. At least 1 of 5 general symptoms â?? feeling tired, weakness, body ache, irritable or whiney, or less active

Exclusion criteria

Exclusion criteria: 1. Severe or complicated course of URTI. 2. Signs of acute lower respiratory tract disease. 3. Current symptoms mainly induced by other acute ENT diseases. 4. Daily use of antibiotics, steroids and cytotoxic agents. 5. Children on active treatment from any other system of medicine. 6. Children with any uncontrolled systemic disease, infection, and any organ failure. 7. Severe co morbidity including previous malignant disease during the past 5 years prior enrolment.

Design outcomes

Primary

MeasureTime frame
Wisconsin Upper Respiratory Symptom Survey (WURSS-21); translated Bengali versionTimepoint: Baseline, 4 (±1) days, 8(±1) days, and 15(±2) days after treatment—

Secondary

MeasureTime frame
Canadian Acute Respiratory Illness and Flu Scale (CARIFS-18); translated Bengali versionTimepoint: Baseline, 4 (±1) days, 8(±1) days, and 15(±2) days after treatment;Symptom Score for RTI (SSRTI); translated Bengali versionTimepoint: Baseline, 4 (±1) days, 8(±1) days, and 15(±2) days after treatment—

Countries

India

Contacts

Public ContactGautam Ash

National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India

dr.gautam.ash01@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026